Xanax and Anion gap increased - a phase IV clinical study of FDA data

Summary:

Anion gap increased is reported as a side effect among people who take Xanax (alprazolam), especially for people who are female, 40-49 old, also take Prilosec, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Anion gap increased when taking Xanax. It is created by eHealthMe based on reports of 126,784 people who have side effects when taking Xanax from the FDA, and is updated regularly.

What is Xanax?

Xanax has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 135,347 Xanax users. Check the latest studies of Xanax.

What is Anion gap increased?

Anion gap increased is found to be associated with 249 drugs and 396 conditions by eHealthMe. Check the latest studies of Anion gap increased.

On Aug, 07, 2026

126,784 people reported to have side effects when taking Xanax.
Among them, 23 people (0.02%) have Anion gap increased.

Among these 23 people:

What is the gender of people who have Anion gap increased when taking Xanax? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Anion gap increased when taking Xanax? *

What are other drugs people take besides Xanax? *

What are other side effects people have besides Anion gap increased? *

Blood Glucose Increased: 16 people, 69.57%
Weakness: 11 people, 47.83%
Intervertebral Disc Degeneration (spinal disc degeneration): 9 people, 39.13%
Haematocrit Decreased: 8 people, 34.78%
Pain: 8 people, 34.78%
Fall: 8 people, 34.78%
Pain In Extremity: 7 people, 30.43%
Red Blood Cell Count Decreased: 7 people, 30.43%
Blood Sodium Decreased: 7 people, 30.43%
Heart Rate Decreased: 7 people, 30.43%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 8 people, 34.78%
Headache (pain in head): 7 people, 30.43%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 30.43%
Pain: 7 people, 30.43%
Skin Blushing/flushing (a sudden reddening of the face, neck): 6 people, 26.09%
Nausea (feeling of having an urge to vomit): 6 people, 26.09%
Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 21.74%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 4 people, 17.39%
Weight Decreased: 2 people, 8.70%
Arthropathy: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Xanax and have Anion gap increased?

- Check whether Anion gap increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xanax:

Xanax (135,347 reports)

Browse all side effects of Xanax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Anion gap increased:

Anion gap increased (249 drugs)

Browse all the conditions that are associated with Anion gap increased:

Anion gap increased (396 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprazolam (the active ingredients of Xanax) and Xanax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.